(Q44992737)

English

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect (English)

1 reference

Europe PubMed Central

8 December 2017

Alexander Claviez

4

1 reference

Europe PubMed Central

8 December 2017

author name string

Glass B

1

1 reference

Europe PubMed Central

8 December 2017

Nickelsen M

2

1 reference

Europe PubMed Central

8 December 2017

Dreger P

3

1 reference

Europe PubMed Central

8 December 2017

Hasenkamp J

5

1 reference

Europe PubMed Central

8 December 2017

Wulf G

6

1 reference

Europe PubMed Central

8 December 2017

Trümper L

7

1 reference

Europe PubMed Central

8 December 2017

Schmitz N

8

1 reference

Europe PubMed Central

8 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

8 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

8 December 2017

34

1 reference

Europe PubMed Central

8 December 2017

5

1 reference

Europe PubMed Central

8 December 2017

391-397

1 reference

Europe PubMed Central

8 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704600

0 references

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

21 January 2018

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704600

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704600

1 reference

Europe PubMed Central

8 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44992737&oldid=2060711947"